The GEP-based Bayesian classifier developed by Wright et al. assigned linear predictor scores (LPS) to DLBCL cases, yet failed to classify 10%–15% of tumors due to ambiguous ABC/GCB signatures, highlighting biological heterogeneity. This evidence concerns the gene ABCB6 and diffuse large B-cell lymphoma.